Dr. Jennifer Walden Has Succeeded In A Male Dominated Field

Surgery has been a field that tends to attract far more men then women. Part of the reason that the field has more men is because it is a very demanding field. People who want to be surgeon must complete a long and intensive course of training. Such is the case for Dr. Jennifer Walden. She has spend a great deal of time studying the human body. During this time, she’s had to devote her energy and attention to her chosen career. In doing so, she’s earned a sense of true satisfaction. As one of the best surgeons in Austin, Texas, she knows that she does not have many female peers. She also knows that she must continue at every turn to demonstrate her devotion to the world surgical excellence. Her life is all about drive and her determination to truly succeed. Despite the long hours required of her, she’s finding a great deal of personal satisfaction in what she does.

Her Remarkable Career

While the vast majority of people who seek out plastic surgery are female, the truth is that very few plastic surgeons are women. This is why Dr. Jennifer Walden is such a great resource for women. She has succeeded in what is a traditionally largely a male field. She shows women that they can do anything they set their minds to no matter what obstacles may lay in their path. Her life and her work are about demonstrating that women are just as capable of mastering complicated techniques in any field. She wants other women to see what she has done and take heart knowing they can work just as hard and succeed very well. Her remarkable career has led her to many places and enabled her to succeed as a woman in a male field. About Welden

Eric Lefkofksy: Centralized Data Collection for Cancer Research

Eric Lefkofksy of TempusLabs explains that Cancer Moonshot tries to address this problem but requires a significant amount of application in order to do so. This is because physicians often use individualized data analysis procedures and techniques, isolating large amounts of patient data. The way that cancer research will improve is by collecting large-scale molecular data with multiple institutions, hospitals and medical centers.

This would take genomic and molecular profiling to a larger level because patients will be able to record much more data as a collective set. Finding relevant patterns through this clinical analysis will help build technology platforms and allows doctors the opportunity to work with new therapies. Biological and digital information can be modeled easier and treatment methods can be more precisely involved in what effects each patient and their condition.

Building scalable research platforms will be central to the development of cancer research and treatment methods in the future. Vivo end in vitro methods can also be used to impact the way patients diseases are defined and treated. The crossover between data analysis software and existing healthcare system infrastructure will allow for cancer research to take place in a responsible and successive way.

Tempus is one organization that aims to help physicians deliver greater care and personalized attention to cancer patients. This is done by including big data and learning tools in the process of documenting and designing treatment plans. Numerous geneticist and biology involved in computational data as well as engineers have been involved with the process of cancer documentation and infrastructure. By creating tools needed to establish molecular information, cancer research can use genetic sequencing and novel therapies when treating cancer patients. These insights are applicable to radiology, pathology, oncology and surgery.

Tempus aims to incorporate data analysis and related software in the way that cancer research takes place in the present and future. Building a platform that connects positions and healthcare research institutes can centralize data collection and allow for larger pools when sampling and and analyzing patient outcomes. These kinds of tools will help improve the way that physicians contribute to research while new technologies are developed over time.

https://www.crunchbase.com/person/eric-lefkofsky